PSA to continue to recognise Advanced Practice Pharmacists


Strong support will continue for Advanced Practice Pharmacists to ensure excellence in pharmacist care and deliver better health outcomes, says PSA in reiterating its support for Advanced Practice Pharmacists.

This follows a decision by the Australian Pharmacy Council to end the national credentialing of pharmacists in advanced practice citing sustainability issues.

PSA National Vice President Michelle Lynch acknowledged the importance of formal recognition of pharmacists working at an advanced level in their area of expert professional practice and says it was disappointing to see formal recognition of advanced practice put on hold.

“We understand the APC’s decision to end their support of this credentialing program for sustainability reasons,” Lynch says.

“However PSA will continue to recognise all members who become credentialed as an Advanced Practice Pharmacist by offering them the opportunity to become Fellows of the Pharmaceutical Society and use the post nominals.”

PSA paid tribute to the significant work of the APC in developing and piloting a national credentialing program to evaluate practitioner performance and guide development by an independent evaluation against the Advanced Pharmacy Practice Framework for Australia.

“PSA will be actively involved in working with the pharmacy profession to ensure the sustainability of the credentialing process for Advanced Practice Pharmacists,” Lynch says.

“As outlined by the Pharmacy Practitioner Development Committee, we look forward to discussions on a future model of recognition and credentialing and working together as ‘one profession’ to ensure sustainability of the credentialing process.”

PSA already supports pharmacists advancing their professional practice through PSA’s Career Pathways and Advanced Practice Support initiatives launched at the PSA16 conference in Sydney in July 2016.

“We will continue to offer our support program of advanced practice development for all pharmacists, in all practice settings, who are interested in advancing their professional practice and evaluating their impact along the practice continuum to provide robust career frameworks,” Lynch says.

 

Previous Choosing Wisely questions more tests
Next New trial to investigate GP-pharmacist collaboration

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.